Article Details

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) CFO Sells $705346.20 in Stock

Retrieved on: 2021-04-27 02:48:45

Tags for this article:

Click the tags to see associated articles and topics

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) CFO Sells $705346.20 in Stock. View article details on hiswai:

Excerpt

Schonfeld Strategic Advisors LLC now owns 249,200 shares of the biotechnology company's stock valued at $641,000 after buying an additional 53,100 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up